Intarcia Therapeutics is a series c plus startup based in United States. 1 investor tracked. Status: dead.
Based in the United States, Intarcia Therapeutics is a startup. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
Intarcia Therapeutics was a biopharmaceutical company focused on the development and commercialization of therapies for chronic diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.